by 
Cell expansion is a process of growing or propagating cells in culture. It is widely used in biomanufacturing and tissue engineering. Cells from small initial samples are expanded into larger pools to produce bulk quantities of biological materials and engineered tissues. The global Cell Expansion Market is estimated to be valued at US$ 16,035.5 Mn in 2023 and is expected to exhibit a CAGR of 11.% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends: Advancements in cell culture technology are driving the cell expansion market. Continuous improvements to cell culture media formulations and substrates have enhanced cell growth, viability, and reproducibility. Advances such as 3D bioreactor systems and microcarriers now allow for scalable expansion of stem cells and other cell types. This is expected to increase consumption of cell expansion products during the forecast period.
SWOT Analysis
Strength: The cell expansion market offers significant growth opportunities owing to rise in demand for regenerative medicines and cell therapies. Additionally, advancements in cell culture techniques and products further propels the market growth.
Weakness: High costs associated with cell-based research and complexity of cell culture techniques poses significant challenges for overall market growth.
Opportunity: Rising prevalence of chronic diseases and growing R&D investment in cell-based research provides potential opportunities for key players in the cell expansion market.
Threats: Stringent regulatory frameworks for cell-based therapeutics and ethics related to stem cell research restrict the smooth development of the cell expansion market.
Key Takeaways
The global cell expansion market is expected to witness high growth. North America currently dominates the cell expansion market owing to presence of major market players and advanced healthcare infrastructure in the region. The cell expansion market in Asia Pacific is expected to witness fastest growth over the forecast period due to increasing healthcare expenditure, rising disposable incomes, and growing focus on stem cell research.
Key players operating in the cell expansion market include Becton, Dickinson and Company, Sartorius AG, Merck KGaA, Corning, Inc., Eppendorf SE, Lonza Group AG, PromoCell, Danaher, Thermo Fisher Scientific, HiMedia Laboratories, STEMCELL Technologies Inc., REPROCELL Inc., Bio-Techne, Valiant Co., Ltd., Miltenyi Biotec, and Biologos. These players are focusing on new product launches, partnerships, and agreements to gain competitive advantage in the market. For instance, in 2022, Sartorius expanded its cell culture media portfolio through acquisition of Biological Industries.
Regional analysis comprises: The Asia Pacific region is expected to witness the fastest growth in the cell expansion market over the forecast period owing to rising healthcare expenditure, increasing focus on stem cell research, and growing collaborations between research institutes and market players in the region. China, India, and Japan are projected to be the major revenue generating countries in Asia Pacific.
Key players related content comprises: Key players operating in the cell expansion market are Becton, Dickinson and Company, Sartorius AG, Merck KGaA, Corning, Inc., Eppendorf SE, Lonza Group AG, PromoCell, Danaher, Thermo Fisher Scientific, HiMedia Laboratories, STEMCELL Technologies Inc., REPROCELL Inc., Bio-Techne, Valiant Co., Ltd., Miltenyi Biotec, and Biologos.
*Note:
- Source: Coherent Market Insights, Public sources, Desk research
- We have leveraged AI tools to mine information and compile it
